Platelets, complement and tissue inflammation

Autoimmunity

Volumn 46, Issue 1, 2013, Pages 1-5

  Ioannou, Antonis ^a   Kannan, Lakshmi ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Autoimmunity; Ischemia reperfusion; Platelets; Rheumatoid arthritis; Systemic lupus erythematosus; Tissue injury

Indexed keywords

CD40 LIGAND; COLLAGEN TYPE 1; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B; FC RECEPTOR IIA; HIGH MOBILITY GROUP B1 PROTEIN; PADGEM PROTEIN; RANTES;

COMPLEMENT ACTIVATION; CROHN DISEASE; ENTERITIS; INFLAMMATION; NONHUMAN; PLATELET MICROPARTICLE; PROTEIN BINDING; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOCYTE; THROMBOCYTE ACTIVATION; ULCERATIVE COLITIS;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD PLATELETS; COMPLEMENT SYSTEM PROTEINS; HUMANS; INFLAMMATION; PLATELET ACTIVATION;

EID: 84872184933     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.722144     Document Type: Review

References (40)

1. Rendu, F., and B. Brohard-Bohn. 2001. The platelet release reaction: Hranules' constituents, secretion and functions. Platelets 12: 261-273. (Pubitemid 32730513)
2. May, A. E., T. Kalsch, S. Massberg, Y. Herouy, R. Schmidt, and M. Gawaz. 2002. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-Dependent matrix degradation by endothelial cells. Circulation 106: 2111-2117. (Pubitemid 35192818)
3. Walz,D. A., V. Y.Wu, R. de Lamo,H. Dene, and L. E. McCoy. 1977. Primary structure of human platelet factor 4. Thromb. Res. 11: 893-898. (Pubitemid 8251864)
4. Kirk, A. D., C. N. Morrell, and W. M. Baldwin, 3rd. 2009. Platelets influence vascularized organ transplants from start to finish. Am. J. Transplant. 9: 14-22.
5. Duffau, P., J. Seneschal, C. Nicco, C. Richez, E. Lazaro, I. Douchet, C. Bordes, J. F. Viallard, C. Goulvestre, J. L. Pellegrin, et al. 2010. Platelet CD154 potentiates interferon-Alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med. 2: 47ra63.
6. Collins, C. E., and D. S. Rampton. 1997. Review article: Platelets in inflammatory bowel disease-pathogenetic role and therapeutic implications. Aliment Pharmacol. Ther. 11: 237-247. (Pubitemid 27183501)
7. Franks, Z. G., R. A. Campbell, A. S. Weyrich, and M. T. Rondina. 2010. Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Ann. N.Y. Acad. Sci. 1207: 11-17.
8. Lapchak, P. H., L. Kannan, A. Ioannou, P. Rani, P. Karian, J. J. Dalle Lucca, and G. C. Tsokos. 2012. Platelets orchestrate remote tissue damage after mesenteric ischemia-Reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 302: H888-G897.
9. Peerschke, E. I., W. Yin, S. E. Grigg, and B. Ghebrehiwet. 2006. Blood platelets activate the classical pathway of human complement. J. Thromb. Haemost. 4: 2035-2042. (Pubitemid 44226786)
10. Del Conde, I., M. A. Cruz, H. Zhang, J. A. Lopez, and V. Afshar-Kharghan. 2005. Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 201: 871-879. (Pubitemid 40524457)
11. Hamad, O. A., K. N. Ekdahl, P. H. Nilsson, J. Andersson, P. Magotti, J. D. Lambris, and B. Nilsson. 2008. Complement activation triggered by chondroitin sulfate released by thrombin receptor-Activated platelets. J. Thromb. Haemost. 6: 1413-1421. (Pubitemid 352016323)
12. Morel, O., F. Toti, B. Hugel, and J. M. Freyssinet. 2004. Cellular microparticles: A disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11: 156-164. (Pubitemid 38952003)
13. Zeiger, F., S. Stephan, G. Hoheisel,D. Pfeiffer, C. Ruehlmann, and M. Koksch. 2000. P-Selectin expression, platelet aggregates, and platelet-Derived microparticle formation are increased in peripheral arterial disease. Blood Coagul. Fibrinolysis 11: 723-728. (Pubitemid 32010206)
14. Choudhury, A., I. Chung, AD. Blann, and GY. Lip. 2007. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: Relationship to p-Selectin and antithrombotic therapy. Chest 131: 809-815. (Pubitemid 46446874)
15. Piccin, A., W. G. Murphy, and O. P. Smith. 2007. Circulating microparticles: Pathophysiology and clinical implications. Blood Rev. 21: 157-171. (Pubitemid 46529055)
16. Yin, W., B. Ghebrehiwet, and E. I. Peerschke. 2008. Expression of complement components and inhibitors on platelet microparticles. Platelets 19: 225-233. (Pubitemid 351574446)
17. Tschopp, J., D. E. Jenne, S. Hertig, K. T. Preissner, H. Morgenstern, AP. Sapino, and L. French. 1993. Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into alpha-granules. Blood 82: 118-125. (Pubitemid 23188754)
18. Tsokos, G. C. 2011. Systemic lupus erythematosus.N. Engl. J. Med. 365: 2110-2121.
19. Navratil, J. S., S. Manzi, A. H. Kao, S. Krishnaswami, C. C. Liu, M. J. Ruffing, P. S. Shaw, A. C. Nilson, E. R. Dryden, J. J. Johnson, et al. 2006. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum. 54: 670-674. (Pubitemid 43228646)
20. McInnes, I. B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365: 2205-2219.
21. Boilard, E., P. A. Nigrovic, K. Larabee, G. F. Watts, J. S. Coblyn, M. E. Weinblatt, E. M. Massarotti, E. Remold-O'Donnell, R. W. Farndale, J. Ware, et al. 2010. Platelets amplify inflammation in arthritis via collagen-Dependent microparticle production. Science 327: 580-583.
22. Postlethwaite, A. E., and T. M. Chiang. 2007. Platelet contributions to the pathogenesis of systemic sclerosis. Curr. Opin. Rheumatol. 19: 574-579. (Pubitemid 47530878)
23. Kahaleh, M. B., I. Osborn, and E. C. Leroy. 1982. Elevated levels of circulating platelet aggregates and beta-Thromboglobulin in scleroderma. Ann. Intern. Med. 96: 610-613. (Pubitemid 12111119)
24. Goodfield, M. J., M. A. Orchard, and N. R. Rowell. 1993. Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis. Br. J. Haematol. 84: 675-680. (Pubitemid 23248061)
25. Pattanaik, D., M. Brown, and A. E. Postlethwaite. 2011. Vascular involvement in systemic sclerosis (scleroderma). J. Inflamm. Res. 4: 105-125.
26. Agache, I., M. Radoi, and L. Duca. 2007. Platelet activation in patients with systemic scleroderma-pattern and significance. Rom. J. Intern. Med. 45: 183-191.
27. Yoshizaki, A., K. Komura, Y. Iwata, F. Ogawa, T. Hara, E. Muroi, M. Takenaka, K. Shimizu, M. Hasegawa, M. Fujimoto, et al. 2009. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: Association with disease severity. J. Clin. Immunol. 29: 180-189.
28. Chiang, T. M., H. Takayama, and A. E. Postlethwaite. 2006. Increase in platelet non-Integrin type I collagen receptor in patients with systemic sclerosis. Thromb. Res. 117: 299-306. (Pubitemid 41832302)
29. Kowal-Bielecka, O., K. Kowal, A. Lewszuk, A. Bodzenta-Lukaszyk, J. Walecki, and S. Sierakowski. 2005. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Ann. Rheum. Dis. 64: 484-486. (Pubitemid 40283066)
30. Bamias, G., and F. Cominelli. 2007. Immunopathogenesis of inflammatory bowel disease: Current concepts. Curr. Opin. Gastroenterol. 23: 365-369. (Pubitemid 46878946)
31. Harries, A. D., N. J. Beeching, S. J. Rogerson, and F. J. Nye. 1991. The platelet count as a simple measure to distinguish inflammatory bowel disease from infective diarrhoea. J. Infect. 22: 247-250.
32. Kapsoritakis, A. N., M. I. Koukourakis, A. Sfiridaki, S. P. Potamianos, M. G. Kosmadaki, I. E. Koutroubakis, and E. A. Kouroumalis. 2001. Mean platelet volume: A useful marker of inflammatory bowel disease activity. Am. J. Gastroenterol. 96: 776-781. (Pubitemid 32240730)
33. Collins, C. E., M. R. Cahill, A. C. Newland, and D. S. Rampton. 1994. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106: 840-845. (Pubitemid 24109268)
34. Sankey, E. A., A. P. Dhillon, A. Anthony, A. J. Wakefield, R. Sim, L. More, M. Hudson, A. M. Sawyerr, and R. E. Pounder. 1993. Early mucosal changes in Crohn's disease. Gut 34: 375-381. (Pubitemid 23080265)
35. Danese, S., C. de la Motte, A. Sturm, J. D. Vogel, G. A. West, S. A. Strong, S. A., J. A. Katz, and C. Fiocchi. 2003. Platelets trigger a CD40-Dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124: 1249-1264. (Pubitemid 36531801)
36. Suzuki, K., K. Sugimura, K. Hasegawa, K. Yoshida, A. Suzuki, K. Ishizuka, K. Ohtsuka, T. Honma, R. Narisawa, and H. Asakura. 2001. Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand. J. Gastroenterol. 36: 1301-1306. (Pubitemid 33027810)
37. Ioannou, A., J. Dalle Lucca, and G. C. Tsokos. 2011. Immunopathogenesis of ischemia/reperfusion-Associated tissue damage. Clin. Immunol. 141: 3-14.
38. Lapchak, P. H., A. Ioannou, L. Kannan, P. Rani, J. J. Dalle Lucca, and G. C. Tsokos. 2012. Platelet-Associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury. PLoS One 7: E32260.
39. Lapchak, P. H., A. Ioannou, P. Rani, L. A. Lieberman, K. Yoshiya, L. Kannan, J. J. Lucca, M. A. Kowalska, and G. C. Tsokos. 2012. The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury. PLoS One 7: E39934.
40. Lapchak, P. H., L. Kannan, P. Rani,O.N. Pamuk, A. Ioannou, J. J. Dalle Lucca, P. Pine, and G. C. Tsokos. 2012. Inhibition of Syk activity by R788 in platelets prevents remote lung tissue damage after mesenteric ischemia-Reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 302: H1416-G1422.